Call MEDISCA now at 1-800-932-10391-800-665-6334

Medisca News

Medisca to Open New Plattsburgh, N.Y. Facility Exceeding Rigorous Quality and Employee Safety Standards

October 27, 2022

Medisca, a global company offering pharmaceutical compounding products and services, mixing technology, manufacturing, education services and more, announces plans to lease a standalone 60,000 square foot building to consolidate repackaging and distribution operations in Plattsburgh, NY under one roof.

Medisca Unveils New Brand Identity and Corporate Positioning as Partners in Wellness

August 22, 2022

After three successful decades of redefining, shaping, and informing the pharmaceutical compounding industry standard, Medisca is proud to unveil a new global brand identity and corporate positioning that reflects a journey of growth, diversification, and opportunity. Founded in 1989 as a small business with a handful of employees, Medisca has expanded into a global corporation with strategic partners in education, manufacturing, supply chain, and analytical testing that deliver customized solutions with an unwavering commitment to quality and innovation.

Medisca Acquires all IP assets of Maxima Pharmaceuticals Including the DIFFUSIMAX® Brand

June 28, 2022

On May 31, 2022, Medisca, a global supplier of pharmaceutical compounding products, acquired DIFFUSIMAX® and DIFFUSIMAX®10 liposomal bases (pluronic lecithin organogel or PLO gel), products used for preparing compounded topical formulations, as well as all intellectual property assets of Maxima Pharmaceuticals.

Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA

June 1, 2022

MONTREAL, Q.C. (May 26, 2022) – On March 16, 2022, Medisca, a global supplier of pharmaceutical ingredients and equipment, entered into an exclusive agreement with SUANFARMA, European-based manufacturer and distributor of pharmaceutical ingredients, for the global supply and distribution of Thyroid Powder, USP, by leveraging its exclusive partnership with pharmaceutical manufacturer, Sichuan Deebio Pharmaceutical Co., Ltd (Deebio).

Medisca Pledges Another $100,000 in Matching Donations to the Alliance for Pharmacy Compounding Media Campaign Fund to Secure Compounded Hormone Therapy.

March 25, 2022

PLATTSBURGH, N.Y. (March 25, 2022) – Less than a year later, Medisca is back to pledge another $100,000 in matching donations to the Alliance for Pharmacy Compounding (APC) Media Campaign Fund, a three-year initiative to secure compounded hormone therapy through media and congressional engagement.

Medisca Signs Deal as Exclusive Global Distributor outside the USA & Israel for the Padagis Line of ORA Products

January 12, 2022

MONTREAL, Q.C. (January 12, 2022) – On December 9, 2021, Medisca entered into an exclusive global manufacture, supply, license and distribution agreement with Padagis (formerly, the Rx Division of Perrigo) for their ORA Product Line consisting of the following Padagis products in finished form ORA-Plus®, ORA-Sweet®, ORA-Sweet® SF, ORA-Blend®, and ORA-Blend® SF.

ARCHIVE


GO BACK


X

We have placed cookies on your device to help make this website better.

We also use cookies to collect information for making reports and to help us improve the site. The cookies collect information in an anonymous form.



Copyright® 1989-2023 Medisca Inc.
All rights reserved